Angelini Ventures invests into extended €75.8 million Series C financing round for Nouscom to advance neoantigen cancer vaccines
Amount Raised
$75.8 Million
Round Type
Series C
BaselBiotechnologyHealth CareTherapeuticsInvestors
Description
Angelini Ventures joins the syndicate of top-tier international healthcare investors in Nouscom’s Series C financing round, adding €7 million to the oversubscribed financing round, bringing the total raised to €75.8 million. This funding will enable Nouscom to continue advancing the clinical development of its portfolio of neoantigen cancer vaccines to key clinical proof-of-concept endpoints.
Quick answer
Nouscom raised $75.8 Million in a Series C round, dated March 21, 2024. Investors: Versant Ventures, EQT Life Sciences, 5 Am Ventures, X Gen Ventures, Panakès Partners, Indaco Venture Partners, Revelation Partners and M Ventures. Nouscom is based in Basel, Basel City, Switzerland.
- How much did Nouscom raise?
- Nouscom raised $75.8 Million in a Series C round on March 21, 2024.
- Who invested in Nouscom?
- Versant Ventures, EQT Life Sciences, 5 Am Ventures, X Gen Ventures, Panakès Partners, Indaco Venture Partners, Revelation Partners and M Ventures are named as investors in this round.
- What does Nouscom do?
- Nouscom is a private clinical stage immuno-oncology company developing off-the-shelf and personalized cancer immunotherapies using proprietary viral vectors with demonstrated high immunogenicity in patients.
- Where is Nouscom based and how big is it?
- Nouscom is based in Basel, Basel City, Switzerland. Fundz records about 11 employees.
- Who are the decision-makers at Nouscom?
- Fundz holds 1 contact at Nouscom. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Nouscom that raised within 45 days of this round, from Fundz verified event records.
- BridgeBio raised $200M (Pre-Seed) on May 3, 2024.
- Zenas BioPharma raised $200M on May 3, 2024.
- Delphia Therapeutics raised $67M (Series A) on May 2, 2024.
- Novocure raised $400M (Debt Financing) on May 2, 2024.
- Scipher Medicine raised $25M on May 2, 2024.
- Medicenna raised $15M on April 30, 2024.
Who to call at Nouscom, and when
A new round usually means Nouscom is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nouscom raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nouscom, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nouscom. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nouscom raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nouscom raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.